FDA Drug Shortages

Tier 1: Established: peer-reviewed research or government health authority
Publisher: U.S. Food and Drug Administration · Published: August 10, 2026 · Accessed: August 10, 2026

Visit the source ↗

Claims this source supports

• The FDA maintains a public list of drugs in shortage, driven by manufacturer-reported supply information.
• As of mid-2026, estradiol patches have not been added to the FDA shortage list; the agency stated manufacturers are reporting full-capacity production while working to keep up with increased demand.
• FDA spokesperson: if national supply falls into shortage, it will be posted on the agency's drug shortage website.